Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Genetic Testing × Tumor-Agnostic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Breast 17 Gastrointestinal 15 Genitourinary 12 Gynecologic 10 CNS 8 Other hematologic neoplasm 5 Other solid neoplasm 4 Lymphoid 3 Head & Neck 3 Sarcoma 2 Tumor-Agnostic 1 Thoracic 1 Plasma cell 1 Other neoplasm 1 Myeloid 1 Endocrine 1 Dermatologic 1 Classical hematology 1

Conditions

Interventions

pembrolizumab 85 Paclitaxel 74 Carboplatin 67 Gemcitabine 65 Surveys and Questionnaires 58 Nivolumab 53 Cisplatin 50 Bevacizumab 48 Docetaxel 47 Magnetic Resonance Spectroscopy 43 Fluorouracil 39 Capecitabine 39 Blood Specimen Collection 39 Radiotherapy 37 Irinotecan 32 Biopsy 32 Oxaliplatin 31 Erlotinib Hydrochloride 31 Pemetrexed 30 Standard of Care 29 Specimen Handling 29 atezolizumab 27 Trastuzumab 27 Leucovorin 27 Radiosurgery 26 Sorafenib 24 Ipilimumab 24 Interviews as Topic 24 Everolimus 24 Cyclophosphamide 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06008392 2025-10-10

INTERCEPTioN

Mayo Clinic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡